Meet our next-generation FIREScript® reverse transcriptases: fast, thermostable enzymes with distinct RNase H profiles for flexible cDNA synthesis and RT-qPCR workflows.
Summer has a way of changing the rhythm of a laboratory. Temperatures rise, team members take well-earned holidays, and deliveries do not always arrive exactly when expected. A shipment may take longer in transit than planned. A package might reach the laboratory on a particularly hot afternoon. With Solis BioDyne’s products, summer heat does not have to bring research to a standstill.
From 2010, Solis BioDyne had stepped into a whole new area of enzyme development. What began as an ambitious R&D project led to FIREScript®, SOLIScript®, RiboGrip® RNase Inhibitor, and the SolisFAST® product line. Find out more about the development process in this blog post.
In high-throughput environments such as diagnostic kit development, pharmaceutical research, and OEM manufacturing, reducing PCR and qPCR costs is rarely as simple as choosing the lowest-priced reagent. Cost per reaction is often the first metric considered, but it does not fully reflect the true financial impact of a workflow.